低级别和间变性胶质瘤患者长期无癫痫发作后抗癫痫药物撤药:一项前瞻性观察性研究
这项前瞻性观察性研究纳入组织学确诊的低级别或间变性胶质瘤患者,评估抗癫痫药物(AED)撤药的共同决策过程及撤药后癫痫复发结局。83例符合标准,71例纳入分析,46例决定撤药;撤药组26%(12/46)出现癫痫复发,继续用药组8%(2/25)复发。作者结论认为AED撤药应仅在推测肿瘤进展风险低的精心选择患者中考虑。
要点
- 65%(46/71)患者经共同决策选择撤药,撤药组癫痫复发率26%(12/46)。
- 撤药组12例复发中7例(58%)伴肿瘤进展,其中3例在复发后3个月内发现。
- 继续用药组癫痫复发率8%(2/25),其中1例伴肿瘤进展。
核心结论
- 65%的患者经共同决策决定撤药,撤药后26%出现癫痫复发。
- AED撤药应仅在推测肿瘤进展风险低的精心选择患者中考虑。
研究设计与样本
- 前瞻性观察性研究,纳入组织学确诊的低级别或间变性胶质瘤患者。
- 入组条件为自末次抗肿瘤治疗之日起无癫痫发作≥1年,或若癫痫发作发生在末次抗肿瘤治疗结束后,则自末次发作起无癫痫发作≥2年。
- 患者与神经肿瘤科医生共同决策AED撤药或继续治疗,主要结局为共同决策过程和癫痫复发率。
- 83例符合全部入组标准,其中12/83(14%)因神经肿瘤科医生强烈反对撤药而未纳入分析,最终分析71/83(86%)例。
主要发现
- 撤药组26%(12/46)在随访期间出现癫痫复发。
- 撤药组12例复发患者中7例(58%)伴肿瘤进展,其中3例在癫痫复发后3个月内发现肿瘤进展。
- 继续用药组8%(2/25)出现癫痫复发,其中1例伴肿瘤进展。
临床怎么用
- 作者认为AED撤药应仅在推测肿瘤进展风险低的精心选择患者中考虑。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When glioma patients experience long-term seizure freedom the question arises whether antiepileptic drugs (AEDs) should be continued. As no prospective studies exist on seizure recurrence in glioma patients after AED withdrawal, we evaluated the decision-making process to withdraw AEDs in glioma patients, and seizure outcome after withdrawal. METHODS: Patients with a histologically confirmed low grade or anaplastic glioma were included. Eligible patients were seizure free ≥ 1 year from the date of last antitumor treatment, or ≥ 2 years since the last seizure when seizures occurred after the end of the last antitumor treatment. Patients and neuro-oncologists made a shared decision on the preferred AED treatment (i.e. AED withdrawal or continuation). Primary outcomes were: (1) outcome of the shared decision-making process and (2) rate of seizure recurrence. RESULTS: Eighty-three patients fulfilled all eligibility criteria. However, in 12/83 (14%) patients, the neuro-oncologist had serious objections to AED withdrawal. Therefore, 71/83 (86%) patients were analyzed; In 46/71 (65%) patients it was decided to withdraw AED treatment. In the withdrawal group, 26% (12/46) had seizure recurrence during follow-up. Seven of these 12 patients (58%) had tumor progression, of which three within 3 months after seizure recurrence. In the AED continuation group, 8% (2/25) of patients had seizure recurrence of which one had tumor progression. CONCLUSION: In 65% of patients a shared decision was made to withdraw AEDs, of which 26% had seizure recurrence. AED withdrawal should only be considered in carefully selected patients with a presumed low risk of tumor progression.
引用
- Kerkhof M, Koekkoek JAF, Vos MJ, et al. Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study. J Neurooncol. 2019. PMID: 30778733. doi:10.1007/s11060-019-03117-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。